Related Experiment Videos
Complement levles in relation to certain antibodies in polytransfused thalassaemic patients
Vox Sanguinis
|January 1, 1976
Summary
Polytransfused patients develop numerous antibodies, including anti-HBs and anti-smooth muscle. Low serum complement levels correlate with rheumatoid factor presence in thalassemia patients.
Area of Science:
- Immunology
- Hematology
Background:
- Polytransfused patients face risks of autoimmune reactions due to repeated antigenic exposure.
- Thalassemia patients often require frequent blood transfusions, increasing this risk.
Purpose of the Study:
- To investigate the relationship between serum complement levels and the prevalence of various antibodies in polytransfused thalassemia patients.
- To identify specific antibody profiles associated with transfusion history.
Main Methods:
- Study included 75 polytransfused thalassemia patients.
- Assessed incidence of antibodies such as anti-HBs, anti-Gm, rheumatoid factor, antinuclear, and anti-smooth muscle.
- Measured total hemolytic complement levels.
Main Results:
- High incidence of antibodies: anti-HBs (77%), anti-Gm (64%), anti-smooth muscle (47%), rheumatoid factor (31%), antinuclear (13%).
- Low or decreased serum complement observed in a significant portion of patients.
- A positive correlation identified between low serum complement and the presence of rheumatoid factor.
- High anti-smooth muscle antibody levels appeared independent of liver disease.
Conclusions:
- Polytransfusion in thalassemia patients is associated with a high frequency of autoantibody formation.
- Low serum complement is linked to rheumatoid factor, suggesting immune dysregulation.
- Further research is needed to understand the clinical implications of these findings.